Table 1.

Demographic and clinical characteristics of patients (n = 44) with a diagnosis of post-stroke depression that were included in a retrospective study to investigate whether a therapy based on nootropic drugs was at least as effective as an antidepressant therapy.

Characteristic	Group 1 n = 20	Group 2n = 24	SRD	95% CI
Male	8 (40.0)	15 (62.5)	–0.225	–0.56, 0.11
Age, years	59.9 ± 9.3	63.9 ± 9.6	–0.262	–0.56, 0.10
Education, years	9.5 ± 3.9	8.6 ± 4.2	0.144	–0.20, 0.45
Time since stroke onset, days	71.5 ± 12.4	65.2 ± 10.1	0.079	–0.28, 0.42
MOCA score	19.7 ± 6.4	20.7 ± 4.3	–0.010	–0.36, 0.34
HAM-A score	17.3 ± 7.5	8.3 ± 5.9	0.664	0.37, 0.84
HAM-D score	18.3 ± 5.7	8.9 ± 5.8	0.787	0.52, 0.91
Anxiety improvement	10 (50.0)	2 (8.3)	0.417	0.12, 0.71
Depression improvement	16 (80.0)	11 (45.8)	0.342	0.03, 0.65

Data presented as mean ± SD or n of patients (%).

SRD, success rate difference; CI, confidence interval; MOCA, Montreal Cognitive Assessment; HAM-A, Hamilton Anxiety Rating Scale; HAM-D, Hamilton Depression Rating Scale.